Matthew Perrone

More Americans are injecting themselves with unapproved peptides pitched as ways to build muscle, rejuvenate skin and extend life. The trend is popular among influencers and RFK Jr. allies, but experts are concerned about the risks and long-term safety. apnews.com/article/peptid…

2/8

President Donald Trump has directed his administration to speed up reviews of psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious safety risks. apnews.com/article/ibogai…

“The Wild West is about to become wilder,” said Dr. Peter Lurie, a former FDA official who now leads the nonprofit CSPI. “I don’t see why one would take the path of a proper drug approval if there is now this less rigorous, alternative path to market." apnews.com/article/peptid…

NEW: The FDA will hold a meeting this summer to consider easing restrictions on more than a half-dozen peptides, a group of unapproved injectable chemicals that have been touted by RFK Jr. and others in his MAHA movement. apnews.com/article/peptid…

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity apnews.com/article/eli-li…

Makers of dietary supplements are pushing the FDA to expand the types of ingredients they can put in their products, a change that could open the door to more marketing of peptides, probiotics and other trendy wellness offerings. apnews.com/article/dietar…

During the podcast, Soon-Shiong described his company's drug, Anktiva, as “the most important molecule that could cure cancer.” A few minutes later, he said that while the medicine is approved for bladder cancer, “it actually can treat all cancers.” apnews.com/article/patric…

AI companies are pushing new health chatbots, but experts say you still need to talk to your doctor-- at least, sometimes. youtube.com/shorts/J26yHkR…

“There is no evidence to say that leucovorin will help most people with autism, and there’s certainly no evidence to say it’s safe,” said Dr. Alycia Halladay of the Autism Science Foundation, in an interview.

The FDA has approved leucovorin for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that the drug shows great promise for people with autism. apnews.com/article/autism…

@JulianneMcShane Yes, mentioned the panel lower down in the piece

He was also a participant on the FDA-hosted panel last summer pushing for a black box warning on antidepressants that ACOG called "alarmingly unbalanced"... motherjones.com/politics/2025/…

FDA's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add bold new warnings to antidepressants about unproven pregnancy risks. apnews.com/article/hoeg-u…

@PBS: Five things to consider before asking a chatbot for health advice (by @AP_FDAwriter). Among them: ask two different AIs and see if they agree; don't stay home if you have red flag symptoms like chest pain, shortness of breath. I'm quoted. pbs.org/newshour/healt…

What to know before asking an AI chatbot for health advice apnews.com/article/chatbo…

@AP_RaceCalls is now the place to get election results as soon as @AP declares winners in congressional, presidential and governor’s races across the U.S. AP has been counting the vote since 1848. Follow now and come to APNews.com/Elections for full coverage.

For the first time, the FDA will begin awarding bonus payments to drug reviewers who exceed the agency's PDUFA goals. “If you don't like it, we can get rid of it, but usually everybody loves money,” Makary told FDA staffers Thursday. apnews.com/article/drugs-…

The FDA is laying out a pathway for customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable. apnews.com/article/rare-d…

The FDA will drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products. apnews.com/article/fda-dr…

Shares of $HIMS down more than 25% in morning trading after company drops plan to market knockoff version of $NVO's Wegovy pill: apnews.com/article/wegovy…

Rep. Auchincloss asserts that the FDA has failed to publish or release financial disclosure forms for eight senior FDA officials who vote on which drugs should receive priority vouchers. apnews.com/article/fda-ma…